Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

Yang-Jun Li1, Jie Zhang1, Jing Han1

  • 1Department of Ophthalmology, Tangdu Hospital, The Fourth Military Medical University of the PLA, Xian, Shaanxi 710038, P.R. China.

Insights

Diabetic retinopathy involves increased Ras-related C3 botulinum toxin substrate 1 (Rac1) activation. Inhibiting Rac1 in retinal cells reduced vascular permeability and normalized key protein expressions, suggesting Rac1’s role in diabetic retinal damage.

Area of Science:

  • Biomedical Science
  • Ophthalmology
  • Molecular Biology

Background:

  • Diabetic retinopathy is a leading cause of vision loss.
  • The role of specific signaling pathways, like Ras-related C3 botulinum toxin substrate 1 (Rac1), in diabetic retinopathy pathogenesis is not fully understood.
  • Alterations in blood-retinal barrier integrity are a hallmark of diabetic retinopathy.

Purpose of the Study:

  • To investigate the involvement of Rac1 in the pathogenesis of diabetic retinopathy.
  • To examine the effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in diabetic conditions.

Main Methods:

  • Streptozotocin (STZ)-induced diabetic rat model.
  • High glucose-induced rat retinal endothelial cells (RRECs).
  • Rac1 activation measured by RT-qPCR, immunohistochemistry, and Western blot.
  • VE-cadherin and β-catenin expression analyzed with and without Rac1 inhibition via siRNA.

Main Results:

  • STZ-induced diabetes increased retinal vascular permeability and Rac1 activation.
  • Rac1 activation was elevated in high glucose-induced RRECs.
  • Rac1 inhibition prevented high glucose-induced decrease in VE-cadherin and normalized β-catenin expression.
  • Rac1 inhibition ameliorated hyperpermeability in RRECs.

Conclusions:

  • Diabetes induces changes in retinal Rac1 expression and activation.
  • Rac1 plays a significant role in diabetes-induced blood-retinal barrier damage.
  • Rac1 influences VE-cadherin and β-catenin expression, contributing to diabetic retinopathy pathogenesis.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
6
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
8